"Designing Growth Strategies is in our DNA"

U.S. Acne Treatment Market Size, Share & COVID-19 Impact Analysis, By Product Type (Retinoids, Antibiotics, Isotretinoin, and Others), By Treatment Modality (Oral and Topical), By Age Group (10 to 17, 18 to 44, 45 to 64, and 65 and Above), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106565

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Incidence & Prevalence of Acne, U.S. (2021/2022)
    2. New Product Launches
    3. Pipeline Analysis
    4. Key Industry Developments
    5. Regulatory & Reimbursement Scenario, U.S.
    6. Current Unmet Medical Needs
    7. Treatment Algorithm for the Management of Acne Vulgaris in Adolescents & Young Adults
    8. Impact of COVID-19 on U.S. Acne Treatment Market
  5. U.S. Acne Treatment Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Retinoids
      2. Antibiotics
      3. Isotretinoin
      4. Others
    2. Market Analysis, Insights and Forecast – Treatment Modality
      1. Oral
      2. Topical
    3. Market Analysis, Insights and Forecast – Age Group
      1. 10 to 17
      2. 18 to 44
      3. 45 to 64
      4. 65 and above
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Bausch Health Companies Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. GALDERMA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. GlaxoSmithKline Plc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Allergan
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Mayne Pharma Group Limited
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Reckitt Benckiser Group PLC.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Padagis
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      11. Almirall, S.A
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. Acne Treatment Market Value Share (%), by Product, 2022 & 2030

Figure 2:  U.S. Acne Treatment Market Value Share (%), by Treatment Modality, 2022 & 2030

Figure 3:  U.S. Acne Treatment Market Value Share (%), by Age Group, 2022 & 2030

Figure 4:  U.S. Acne Treatment Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 5:  U.S. Acne Treatment Market Share (%), By Company, 2022

Table 1:  U.S. Acne Treatment Market Revenue (USD billion) Forecast, by Product, 2019-2030

Table 2:  U.S. Acne Treatment Market Revenue (USD billion) Forecast, by Treatment Modality, 2019-2030

Table 3:  U.S. Acne Treatment Market Revenue (USD billion) Forecast, by Age Group, 2019-2030

Table 4:  U.S. Acne Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

U.S. Acne Treatment Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 97
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann